Atlas Trials

Fujian Akeylink Biotechnology Co., Ltd.

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Fujian Akeylink Biotechnology Co., Ltd.

RecordFirmDate
Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B (NCT07709520)Fujian Akeylink Biotechnology Co., Ltd.2026-07-10
Phase IIIB Extension Clinical Trial of Efficacy and Safety of GST-HG141 (Nairevir) Combined With NAs in Chronic Hepatitis B (NCT07588009)Fujian Akeylink Biotechnology Co., Ltd.2026-06-26
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B (NCT06263959)Fujian Akeylink Biotechnology Co., Ltd.2023-12-26
Drug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy Participants (NCT06087055)Fujian Akeylink Biotechnology Co., Ltd.2023-05-12
Food Effects of GST-HG171 Tablets Combined With Ritonavir in Healthy Chinese Participants (NCT06084507)Fujian Akeylink Biotechnology Co., Ltd.2023-05-04
Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Renal Function (NCT06106126)Fujian Akeylink Biotechnology Co., Ltd.2023-02-10
Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets (NCT05637541)Fujian Akeylink Biotechnology Co., Ltd.2023-01-03
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG171 Tablets (NCT05668897)Fujian Akeylink Biotechnology Co., Ltd.2022-10-01
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG121 Tablets (NCT05576584)Fujian Akeylink Biotechnology Co., Ltd.2022-07-19

Track Fujian Akeylink Biotechnology Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.